Risk vs RewardThankfully I sold out the majority of my position in KNR (40K shares) around $3 a number of weeks ago. There was alot of not so subtle hype built into BioCloudless and Ghezzi and his team need to be held accountable for leading investors on. I managed to retain 5K shares and have been sitting on the sidelines thinking what to do next. Do I really want to invest more in this Company and it's management that essentially bungled BioCloud's rollout while all along keeping investors out in the dark while the BioCloudless story unraveled or should I sell my last 5K shares and never look back? Well, I decided today to do the former and pick up another 5K shares of KNR. Why you may ask? RISK VS REWARD! KNR's main business appears to be doing quite well based on quarterly reporting and BioCloud, as bad as things look, will eventually gain some traction. Ghezzi and his team developed an interesting tool in BioCloud and even though they have bungled the rollout, there is value in BioCloud and one has to think that at some point in time meaningful sales will occur. I don't expect 10s of thousands of units, but even a few hundred or a thousand over the next year will add some nice sizzle to quarterly results. The current share price in the low $1s appears to be a very nice gift to investors and even a 35% return from here gets us only back to the recent private placement valuation. When you factor in recent share buybacks and the resent meaningful Ghezzi personal share purchases, I think we are set up nicely for a nice rally. Would Ghezzi toss another 100K$ of his own money into buying shares just to see the share price continue to slide or do you think as an insider he has info that would be favourable to the share price and soon this will come to light? Hmmmm....